Trials / Completed
CompletedNCT00849264
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
a Randomized Controlled Study of Surgical Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Eastern Hepatobiliary Surgery Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is working to evaluate the surgical comprehensive treatment for different types of tumor thrombi in the portal vein for hepatocellular carcinoma patients, to establish a standardized, unified, effective therapeutic program.
Detailed description
Primary liver cancer (PLC) has a great tendency to invade portal vein intravascularly, results in the formation of portal vein tumor thrombus (PVTT), which is a crucial factor that can worsen the prognosis of patients with PLC. In clinical, various treatments have been applied to improve this short-term prognosis, but there was no identical indication for treatment of PLC patients with different PVTT. The objective of this study is to evaluate the surgical comprehensive treatment for different types of tumor thrombi in the portal vein for hepatocellular carcinoma patients, to establish a standardized, unified, effective therapeutic program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | chemotherapy with endostar | 15mg/d×14d |
| DRUG | treatment with CBP and 5-FU | CBP 300mg/d×2d,5-FU 1000mg/d×5d |
| DRUG | treatment with endostar, CBP and 5-FU | CBP 300mg/d×2d,5-FU 1000mg/d×5d ,Endostar 15mg/d×14d |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-12-01
- Completion
- 2010-12-01
- First posted
- 2009-02-23
- Last updated
- 2016-04-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00849264. Inclusion in this directory is not an endorsement.